Vascular Access – Devices providing healthcare professionals access to patients’ vasculature for delivery and withdrawal of fluid and medication, as well as devices to protect health workers by helping prevent needlestick injuries. Vital Care – Devices for managing patients’ airways and body temperature before, during and after surgery. Infusion Therapy – Fluid and medication delivery devices for pain management and the treatment of acute and chronic diseases. We have a direct sales presence in over 20 countries and distribution arrangements in approximately 100 others. We sell to approximately 120 markets and, while the US continues to be our largest single market with around 45% of sales, we continue to build our presence in developing and emerging markets.Īpproximately three-quarters of our end user customers are hospitals with the remainder comprising the alternate care market, such as homecare, clinics, and other surgery centres, as well as OEM relationships. We have operations in over 30 countries with manufacturing concentrated in the US, UK, Mexico, Italy, Germany, Czech Republic, and China. Global Sales: £804 million (last reporting cycle: Full Year Fiscal 2014) Principal Operations Regions Leadership: Chris Holmes, President & CEOĬorporate Parent: Smiths Group plc, a FTSE 100 UK based company Specializing in Infusion Therapy, Vascular Access, Vital Care, and Specialty Products & Services, our products are found in hospital, emergency, home and specialty care environments and are used during critical and intensive care, surgery, post-operative care and for support in managing chronic illness.
We are a leading global manufacturer of specialty medical devices that provides innovative and lifesaving solutions for the world’s healthcare markets. At Smiths Medical, we are passionate about improving and saving the lives of patients through high quality, innovative medical devices and services.
0 kommentar(er)
